Isobutyric Acid → HCID 44201108, compound

HRID 2061183Notes

Reaction equation

HRID 2061183 reaction equation
[C:1]([OH:6])(=O)[CH:2]([CH3:4])[CH3:3].CCN(C(C)C)C(C)C.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[CH2:40]([C:42]1[CH:51]=[C:50]2[C:45]([CH:46]=[C:47]([C:54]3[CH:55]=[C:56]([NH:61]/[C:62](/[NH2:65])=[N:63]/O)[CH:57]=[CH:58][C:59]=3[CH3:60])[C:48](=[O:53])[N:49]2[CH3:52])=[CH:44][N:43]=1)[CH3:41]>CN(C=O)C>[CH2:40]([C:42]1[CH:51]=[C:50]2[C:45]([CH:46]=[C:47]([C:54]3[CH:55]=[C:56]([NH:61][C:62]4[N:63]=[C:1]([CH:2]([CH3:4])[CH3:3])[O:6][N:65]=4)[CH:57]=[CH:58][C:59]=3[CH3:60])[C:48](=[O:53])[N:49]2[CH3:52])=[CH:44][N:43]=1)[CH3:41]

Participants

6

Conditions

Temperature
100 °C

Procedure

To a solution of isobutyric acid (8 μL, 0.09 mmol) in DMF (1 mL) were added DIPEA (16 μL, 0.09 mmol) and HATU (33 mg, 0.09 mmol). After stirring at rt for 15 min 17a (30 mg, 0.09 mmol) was added as a solution in DMF (0.5 mL). The reaction was stirred at rt until complete consumption of 17a was determined by LC/MS and then heated at 100° C. for 1 h. Subsequently the reaction was cooled to rt, filtered and purified by preparative LC/MS to give 7-ethyl-3-(5-(5-isopropyl-1,2,4-oxadiazol-3-ylamino)-2-methylphenyl)-1-methyl-1,6-naphthyridin-2(1H)-one (A104). 1H NMR (400 MHz, d6-DMSO) δ 9.91 (s, 1H), 9.10 (s, 1H), 8.05 (s, 1H), 7.78 (s, 1H), 7.41 (dd, J=8, 2 Hz, 1H), 7.33 (d, J=2 Hz, 1H), 7.23 (d, J=8 Hz, 1H), 3.72 (s, 3H), 3.19 (m, 1H), 3.01 (q, J=7.6 Hz, 2H), 2.08 (s, 3H), 1.36 (t, J=7.6 Hz, 3H), 1.31, (d, J=6.8 Hz, 6H). MS m/z 404.1 (M+1).

Workup

  1. temperatureSubsequently the reaction was cooled to rt
  2. filtrationfiltered
  3. custompurified by preparative LC/MS

Sources & evidence

ORD record
ord-8b89f950de3a41d3980ffb9432eeaddd
Source dataset
uspto-grants-2012_10
Patent number
US08278452B2

Reaction notes

Loading…